Advancing Drug Development for Brain Metastasis: From Target Identification to Clinical Trials
Time: 8:45 am
day: Pre-Conference Workshop Day New
Details:
A deep dive into the critical aspects of drug development for brain metastasis, ultimately accelerating progress in this crucial area of oncology.
This workshop will gather experts to discuss:
- Target identification and validation for brain metastasis
- Leveraging molecular markers and pathways specific to brain metastasis and validating potential drug targets for their efficacy and specificity
- Innovations in drug design and delivery for brain metastasis
- Designing drug molecules to enable BBB penetration, exploring novel delivery systems and harnessing nanotechnology for targeted and susuatined drug release.
- Optimizing preclinical models and trial design for brain metastasis research
- Developing robust preclinical models, incorporating patient-derived xenografts and organoids for accurate drug screening and clinical trial endpoints relevant to brain metastasis treatment efficacy.
